145348-77-2 Usage
General Description
2,3,4,5-Tetrahydro-1-benzoxepin-5-amine is an organic chemical compound with the molecular formula C10H13NO. It is a cyclic amine that contains a benzene ring fused to an oxepine ring with an amine group attached to the fourth carbon atom. 2,3,4,5-TETRAHYDRO-1-BENZOXEPIN-5-AMINE is a heterocyclic amine that has potential applications in the field of medicinal chemistry and drug development. It may have pharmacological properties that make it useful for the treatment of certain medical conditions, although further research and testing would be required to confirm its potential therapeutic uses. Additionally, its chemical structure and properties could make it a valuable building block for the synthesis of other more complex organic compounds in the future.
Check Digit Verification of cas no
The CAS Registry Mumber 145348-77-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,5,3,4 and 8 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 145348-77:
(8*1)+(7*4)+(6*5)+(5*3)+(4*4)+(3*8)+(2*7)+(1*7)=142
142 % 10 = 2
So 145348-77-2 is a valid CAS Registry Number.
145348-77-2Relevant articles and documents
SULFONAMIDE-SUBSTITUTED FUSED 7-MEMBERED RING COMPOUNDS, THEIR USE AS A MEDICAMENT, AND PHARMACEUTICAL PREPARATIONS COMPRISING THEM
-
, (2008/06/13)
The present invention relates to compounds of formula I, in which X1, X2, X3, X4, Y1, Y2, Y3, Y4, R(3), R(4) and R(5) have the meanings mentioned in the specification, their preparation and their use, in particular in pharmaceuticals. The compounds effect the potassium channel or the I Ks channel opened by cyclic adenosine monophosphate (cAMP) and are outstandingly suitable as pharmaceutical active compounds, for example for the prophylaxis and therapy of cardiovascular disorders, in particular arrhythmias, for the treatment of ulcers of the gastrointestinal region or for the treatment of diarrheal disorders.